Results · Jan-Mar 2026
Neuland Laboratories Q4 FY26 results
Sales 20%+, profit 30%+Growth band: sales up 20% or more & profit up 30% or more on the same quarter last year, with a wider operating margin.
Sales grew 136% to ₹776 crore from ₹328 crore in Jan-Mar 2025.
Operating profit grew 502% to ₹307 crore, an operating margin of 39.6% (up 24.0 points from a year ago).
Net profit grew 665% to ₹213 crore from ₹27.8 crore in Jan-Mar 2025.
Against Oct-Dec 2025: sales +77%, net profit +424%.
Get Neuland Laboratories' next results & call in your inbox, the day they're filed.
Free. One short email on the days it files or its shares make a big move, nothing on other days. Unsubscribe in one click.
Jan-Mar 2026 vs a year ago
| ₹ crore | Jan-Mar 2026 | Jan-Mar 2025 | Change |
|---|---|---|---|
| Sales | 776.3 | 328.4 | +136% |
| Operating profit (EBITDA) | 307.3 | 51.1 | +502% |
| Operating margin | 39.6% | 15.6% | +24.0 pts |
| Net profit | 212.7 | 27.8 | +665% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.